GE to sell CR systems carrying Fuji labelMultimodality vendor GE Medical Systems and Fuji Medical SystemsUSA have joined forces in an alliance for sales of computed radiographysystems, the companies announced this month. The agreement isunique
Multimodality vendor GE Medical Systems and Fuji Medical SystemsUSA have joined forces in an alliance for sales of computed radiographysystems, the companies announced this month. The agreement isunique in that it is the first OEM deal that enables another manufacturerto sell Fuji brand equipment, according to FMSU, of Stamford,CT.
The deal with Milwaukee-based GE rounds out Fuji's stable ofOEM partners, which include Siemens, Philips and Toshiba. Thosecompanies sell Fuji CR systems under their own labels.
Under the terms of its agreement with GE, Fuji will providesupport to train GE's sales, service and support personnel inCR technology, with the first GE sales of Fuji equipment to takeplace later this year. Initially, Fuji CR systems will be soldand supported by both companies, with GE assuming sales, installationand service functions after training programs are completed.
The alliance gives GE the ability to bring x-ray studies intoa PACS network, a necessity for the development of filmless hospitalinstallations. GE increased its investment in PACS at last year'sRadiological Society of North America meeting by announcing theformation of its network products and services group (SCAN 12/14/94).
The benefits of the relationship for Fuji are obvious. Theagreement will give Fuji access to GE's large sales force andmassive installed base of x-ray systems. When it comes time toreplace those systems, users will want to purchase new equipmentcapable of digital imaging to avoid obsolescence in the eventthat their institutions go filmless, according to Dave Armstrong,director of Fuji's electronic imaging and equipment group.
Fuji has made heavy investments in CR technology in recentyears, unveiling a new generation of CR readers with improvedresolution and higher throughput (SCAN 2/15/95). Those investmentsare paying off with increased clinical acceptance of CR, accordingto Fuji. For example, the Mayo Clinic recently conducted a technologyassessment of CR that found the technology had better image qualitythan film-screen x-ray systems, Armstrong said. The institution,which has decided to go filmless, did not evaluate mammographyapplications of CR.
"For years we were pushing this market all by ourselves,"Armstrong said. "People have finally come to the realizationthat the technology is there."
Fuji has seen strong demand for CR equipment this year andexpects further improvements, thanks to the GE relationship.
"The U.S. market has taken a giant upswing with an increasein orders in the last six months," Armstrong said. "Ithink GE will help us sell or distribute as part of their productline a tremendous number of chest units over the next few years."
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.